- Home
- ALAR vs ANEB Comparison
ALAR vs ANEB Comparison
Compare ALAR & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- ANEB
- Stock Information
- Founded
- ALAR 2013
- ANEB 2020
- Country
- ALAR Israel
- ANEB United States
- Employees
- ALAR N/A
- ANEB N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- ALAR Technology
- ANEB Health Care
- Exchange
- ALAR Nasdaq
- ANEB Nasdaq
- Market Cap
- ALAR 116.1M
- ANEB 102.7M
- IPO Year
- ALAR 2018
- ANEB 2021
- Fundamental
- Price
- ALAR $16.55
- ANEB $2.60
- Analyst Decision
- ALAR Strong Buy
- ANEB Buy
- Analyst Count
- ALAR 1
- ANEB 2
- Target Price
- ALAR $15.00
- ANEB $8.00
- AVG Volume (30 Days)
- ALAR 90.6K
- ANEB 142.0K
- Earning Date
- ALAR 08-28-2025
- ANEB 09-24-2025
- Dividend Yield
- ALAR N/A
- ANEB N/A
- EPS Growth
- ALAR N/A
- ANEB N/A
- EPS
- ALAR 0.07
- ANEB N/A
- Revenue
- ALAR $30,581,000.00
- ANEB N/A
- Revenue This Year
- ALAR $11.54
- ANEB N/A
- Revenue Next Year
- ALAR $19.42
- ANEB N/A
- P/E Ratio
- ALAR $24.94
- ANEB N/A
- Revenue Growth
- ALAR 4.67
- ANEB N/A
- 52 Week Low
- ALAR $5.45
- ANEB $0.80
- 52 Week High
- ALAR $22.44
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- ALAR 66.68
- ANEB 57.46
- Support Level
- ALAR $15.65
- ANEB $2.22
- Resistance Level
- ALAR $17.27
- ANEB $2.69
- Average True Range (ATR)
- ALAR 0.92
- ANEB 0.20
- MACD
- ALAR 0.11
- ANEB -0.04
- Stochastic Oscillator
- ALAR 83.56
- ANEB 65.52
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.